Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID).
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID).
A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID). Mol Genet Metab. 2011 Nov; 104(3):383-9.
View in:
PubMed
subject areas
Cost-Benefit Analysis
Decision Trees
Humans
Infant, Newborn
Lymphopenia
Markov Chains
Models, Economic
Neonatal Screening
Quality-Adjusted Life Years
Sensitivity and Specificity
Severe Combined Immunodeficiency
T-Lymphocytes